In Focus
H1N1/MRSA Coinfection Associated With High Risk for Death in Kids
The Many Faces of MRSA: Recognizing and Treating New At-Risk PopulationsSkin Infections
- A Challenging Case of Osteoarticular Infection: Implications for Treatment and Management
- MRSA Prevention Effective in a Large Healthcare System
- MRSA, VRE Prevention Ineffective in ICU Intervention
- ICU Cleaning Intervention May Reduce MRSA, VRE Transmission
- Containing the Superbug
- Staphylococcus aureus Infections in US Veterans, Maryland, USA 1999-2008
- Current Controversies: Containing MRSA in the Era of the Blurring of Community and Hospital Strains
- IDSA Issues First Guidelines for Treatment of MRSA
- Infectious Disease Consult: What's in Your Waiting Room?
- Antimicrobial Stewardship for the Community Hospital: Practical Tools & Techniques for Implementation
- Preventing Surgical Site Infections: Best Practice Equals Safe Practice
- Illicit Drug Use and the Risk of USA300 Methicillin-Resistant Staphylococcus aureus Infections With Bacteremia
- Resistance Wars IV. In the Trenches: Case Studies in the War on Resistance
- Prevention of Surgical-Site Infections: Best Practices, Better Outcomes
- Skin and Soft Tissue Infections in Immunocompetent Patients Reviewed
- Roadmap for HAI Prevention Research: Bench to Bedside and Back
- Community-Associated Methicillin-Resistant Staphylococcus aureus Strains in Pediatric Intensive Care Unit
- Staphylococcus aureus Bacteremia and Endocarditis: Making an Impact on Outcomes
- Community-Associated Methicillin-Resistant Staphylococcus aureus in Outpatients, United States, 1999-2006
- Community-Associated Methicillin-Resistant Staphylococcus aureus, Iowa, USA
- Management of MRSA in the Community Setting: Getting it Right the First Time
- MRSA in the Community: Best Practices for Early Management and Treatment of Skin and Soft-Tissue Infections
- Managing MRSA in the Community Practice Setting
- MRSA: Managing an Elusive Pathogen
- Diagnosis: MRSA -- The Clinical Challenge of Multidrug-Resistant Infections
- MRSA and Oral Antibiotics for Acne
Pulmonary Infections
- MRSA in Patients With Cystic Fibrosis Linked to Shorter Survival Time
- FDA Approvals: ACTOplus met XR, Azor, Vancomycin HCl Injection
- Resistance Wars III: On the Frontlines of Serious Infections
- Empiric Antimicrobials in Pneumonia: Balancing Risk Against Benefit in an Era of Resistance
- Respiratory Infections: Ventilator-Associated Pneumonia and Healthcare-Associated Pneumonia
Related Resources
- From NFID
Fact Sheet: Community-Associated Methicillin-Resistant Staphylococcus Aureus - Clinical Updates in Infectious Diseases
- From the CDC
National MRSA Education Initiative: Materials for Healthcare Professionals - National MRSA Educaton Initiative: Treatment Algorithm for Skin and Soft Tissue Infections
About MRSA
- Methicillin-resistant Staphylococcus aureus (MRSA), a strain of S aureus that is resistant to beta lactam antibiotics, is an important cause of infection in the US and worldwide. Until recently, healthcare-associated-MRSA and community-associated-MRSA (CA-MRSA) could be distinguished clinically and microbiologically. CA-MRSA is now a significant cause of healthcare-associated infections and is a rapidly emerging public health problem.